Newsletter

Rheumatoid Arthritis
Mapping out the Rheumatoid arthritis market outlook
Rheumatoid Arthritis Newsletter

More Whitepapers / Newsletters

Current Treatment Challenges Of IO Refractory Patients And Clinical Development Of Therapies Targeting These Patients
Current Treatment Challenges O...

Over the years, the Oncology domain has experienced the entry of several treatment approaches. Therapeutic approaches such as surgery, radiation therapy, and chemotherapy form the conventional methods...

Generalized Myasthenia Gravis Newsletter
Generalized Myasthenia Gravis

Myasthenia Gravis is a chronic autoimmune neuromuscular disease responsible for weakness in the skeletal muscles, including the muscles of arms and legs, leading to breathing difficulty and mobility i...

Schizophrenia Market
Schizophrenia

Schizophrenia is a severe mental illness that interferes with a person's ability to think clearly, manage emotions, make decisions, and relate to others. It is a complex, long-term medical illness, af...

Adult Onset Still's Disease
Adult Onset Still's Disease

Affecting the entire body, Adult Onset Still's disease (AOSD) is a rare type of inflammatory arthritis that affects most people before the age of 45. The symptoms of the disease usually begin with a...

Biosimilars: Evidence From Europe
Biosimilars: Evidence From Eur...

The EU market contains more than 55 biosimilars for around 15 oncology, autoimmune, diabetes, and fertility biologic therapies. Although the expiry of patent protection for biologics has resulted in i...